Adjuvant Treatment in Carcinoma of Endometrium: Where Do We Stand?

Abstract

Endometrial cancer is one of the most common gynecological malignancy worldwide. Though there are a large number of completed prospective and retrospective studies, adjuvant treatment remains poorly defined, mainly due to the heterogeneity in selection criteria, different treatment approaches and  low recurrence rates in good risk early stage disease. This article comprehensively covers the different risk stratification approaches and the current concepts and evidences in tailoring of adjuvant treatment in carcinoma of the endometrium.

Keywords: Endometrial cancer, malignancy, endometrium treatment

Cite this Article

Kunheri B, Vijayakumar DK, Anand RK. Adjuvant Treatment in Carcinoma of Endometrium: Where Do We Stand? Research & Reviews: Journal of Oncology and Hematology. 2016; 5(3): 22–29p.